Ten patients (1.33%) were identified with a BRCA2 P/LP variant; five were diagnosed with diffuse, three with intestinal, one with mixed GC, and one with unknown GC histology, with age of diagnosis ranging between 40 years and 81 years; five of them had a family history of GC, and four did not have a GC family history but had a family history of other cancer types, including breast and ovarian cancer. This evidence concerns the gene BRCA2 and ovarian cancer.